301393 Stock Overview
Manufactures and sells chemicals for pharmaceutical research and development, and API production companies.
| Snowflake Score | |
|---|---|
| Valuation | 1/6 |
| Future Growth | 0/6 |
| Past Performance | 2/6 |
| Financial Health | 6/6 |
| Dividends | 2/6 |
Rewards
Risk Analysis
No risks detected for 301393 from our risk checks.
Suzhou Highfine Biotech Co., Ltd. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | CN¥46.33 |
| 52 Week High | CN¥118.80 |
| 52 Week Low | CN¥33.26 |
| Beta | 0 |
| 11 Month Change | 25.62% |
| 3 Month Change | 14.68% |
| 1 Year Change | -37.94% |
| 33 Year Change | n/a |
| 5 Year Change | n/a |
| Change since IPO | -47.58% |
Recent News & Updates
Recent updates
Shareholder Returns
| 301393 | CN Pharmaceuticals | CN Market | |
|---|---|---|---|
| 7D | 30.9% | 25.7% | 26.5% |
| 1Y | -37.9% | -1.6% | 1.2% |
Return vs Industry: 301393 underperformed the CN Pharmaceuticals industry which returned -1.6% over the past year.
Return vs Market: 301393 underperformed the CN Market which returned 1.2% over the past year.
Price Volatility
| 301393 volatility | |
|---|---|
| 301393 Average Weekly Movement | 6.9% |
| Pharmaceuticals Industry Average Movement | 6.1% |
| Market Average Movement | 6.4% |
| 10% most volatile stocks in CN Market | 9.4% |
| 10% least volatile stocks in CN Market | 4.5% |
Stable Share Price: 301393's share price has been volatile over the past 3 months.
Volatility Over Time: 301393's weekly volatility (7%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2003 | n/a | Yong Zhu | www.highfine.com |
Suzhou Highfine Biotech Co., Ltd. manufactures and sells chemicals for pharmaceutical research and development, and API production companies. The company offers peptide synthesis reagents, molecular building blocks, protein crosslinkers, liposomes, ionic liquids, protective amino acids reagents, and nucleotide reagents, as well as unnatural amino acids. Its products are used in the fields of peptide, nucleotide, and pharmaceutical synthesis.
Suzhou Highfine Biotech Co., Ltd. Fundamentals Summary
| 301393 fundamental statistics | |
|---|---|
| Market cap | CN¥4.97b |
| Earnings (TTM) | CN¥106.05m |
| Revenue (TTM) | CN¥403.75m |
46.9x
P/E Ratio12.3x
P/S RatioIs 301393 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 301393 income statement (TTM) | |
|---|---|
| Revenue | CN¥403.75m |
| Cost of Revenue | CN¥260.62m |
| Gross Profit | CN¥143.13m |
| Other Expenses | CN¥37.08m |
| Earnings | CN¥106.05m |
Last Reported Earnings
Jun 30, 2024
Next Earnings Date
Oct 30, 2024
| Earnings per share (EPS) | 0.99 |
| Gross Margin | 35.45% |
| Net Profit Margin | 26.27% |
| Debt/Equity Ratio | 0% |
How did 301393 perform over the long term?
See historical performance and comparison